Homozygous CFTR mutation M348K in a boy with respiratory symptoms and failure to thrive. Disease-causing mutation or benign alteration?
- PMID: 22274833
- DOI: 10.1007/s00431-012-1672-1
Homozygous CFTR mutation M348K in a boy with respiratory symptoms and failure to thrive. Disease-causing mutation or benign alteration?
Abstract
We report on a 6-month-old premature boy from consanguineous parents. He presented with respiratory distress, necrotizing enterocolitis and hyperbilirubinemia shortly after birth. Persisting respiratory symptoms and failure to thrive prompted cystic fibrosis diagnostics, which showed the lack of wild-type signal for the mutation R347P suggesting a homozygous deletion or an alteration different from the known mutation at this position. Sequencing of this region revealed the homozygous substitution 1175 T > A (HGVS: c.1043 T > A) in exon 7 resulting in the homozygous amino acid change M348K. This mutation has never been reported in homozygosity before. Computational analysis tools classified M348K as 'presumably disease causing.' In our patient, sweat testing and electrophysiological assessment of CFTR function in native rectal epithelium demonstrated normal Cl(-) secretion.
Conclusion: We assume that the homozygous alteration M348K is a harmless variant rather than a CF-causing mutation.
Similar articles
-
Incidental Finding of a Homozygous p.M348K Asymptomatic Italian Patient Confirms the Many Faces of Cystic Fibrosis.Case Rep Genet. 2015;2015:289627. doi: 10.1155/2015/289627. Epub 2015 Apr 1. Case Rep Genet. 2015. PMID: 25922769 Free PMC article.
-
Severe CF manifestation with anaemia and failure to thrive in a 394delTT homozygous patient.J Cyst Fibros. 2004 Mar;3(1):58-60. doi: 10.1016/j.jcf.2003.12.009. J Cyst Fibros. 2004. PMID: 15463888
-
Buccal cell DNA mutation analysis for diagnosis of cystic fibrosis in newborns and infants inaccessible to sweat chloride measurement.Pediatrics. 1998 May;101(5):851-5. doi: 10.1542/peds.101.5.851. Pediatrics. 1998. PMID: 9565413
-
[Infantile cholestasis caused by CFTR mutation: case report and literature review].Zhonghua Er Ke Za Zhi. 2016 Nov 2;54(11):851-855. doi: 10.3760/cma.j.issn.0578-1310.2016.11.013. Zhonghua Er Ke Za Zhi. 2016. PMID: 27806795 Review. Chinese.
-
Efficacy and Safety of CFTR Corrector and Potentiator Combination Therapy in Patients with Cystic Fibrosis for the F508del-CFTR Homozygous Mutation: A Systematic Review and Meta-analysis.Adv Ther. 2019 Feb;36(2):451-461. doi: 10.1007/s12325-018-0860-4. Epub 2018 Dec 15. Adv Ther. 2019. PMID: 30554331
Cited by
-
Incidental Finding of a Homozygous p.M348K Asymptomatic Italian Patient Confirms the Many Faces of Cystic Fibrosis.Case Rep Genet. 2015;2015:289627. doi: 10.1155/2015/289627. Epub 2015 Apr 1. Case Rep Genet. 2015. PMID: 25922769 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical